Professional
Added to YB: 2025-11-03
Pitch date: 2025-09-30
KVUE [neutral]
Kenvue Inc.
+7.44%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
Market Cap
$33.2B
Pitch Price
$16.02
Price Target
N/A
Dividend
4.79%
EV/EBITDA
11.47
P/E
23.18
EV/Sales
2.74
Sector
Personal Care Products
Category
value
Show full summary:
Meridian Hedged Equity Fund Portfolio Holding: Kenvue Inc.
KVUE (holding update): Consumer health co w/ Tylenol, Listerine, Neutrogena brands spun from J&J. Value unlock opportunities via reinvestment in underfunded brands, cost optimization & margin improvement. Stock dropped on acetaminophen-autism study concerns but <1% rev from pregnant women & no causal link established.
Read full article (1 min)